State Street’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-2,994,000
| Closed | -$141M | – | 4372 |
|
|
2025
Q2 | $141M | Buy |
2,994,000
+77,659
| +3% | +$3.45M | 0.01% | 1124 |
|
|
2025
Q1 | $129M | Sell |
2,916,341
-84,645
| -3% | -$3.9M | 0.01% | 1141 |
|
|
2024
Q4 | $108M | Sell |
3,000,986
-89,566
| -3% | -$3.13M | ﹤0.01% | 1294 |
|
|
2024
Q3 | $99M | Buy |
3,090,552
+3,707
| +0.1% | +$139K | ﹤0.01% | 1328 |
|
|
2024
Q2 | $116M | Buy |
3,086,845
+125,221
| +4% | +$5.27M | 0.01% | 1170 |
|
|
2024
Q1 | $146M | Buy |
2,961,624
+341,974
| +13% | +$15.8M | 0.01% | 1068 |
|
|
2023
Q4 | $95.6M | Buy |
2,619,650
+48,454
| +2% | +$1.26M | ﹤0.01% | 1316 |
|
|
2023
Q3 | $59.4M | Sell |
2,571,196
-584,355
| -19% | -$16M | ﹤0.01% | 1519 |
|
|
2023
Q2 | $82.7M | Buy |
3,155,551
+344,280
| +12% | +$9.05M | ﹤0.01% | 1348 |
|
|
2023
Q1 | $72.4M | Sell |
2,811,271
-944,418
| -25% | -$27.6M | ﹤0.01% | 1402 |
|
|
2022
Q4 | $97.7M | Buy |
3,755,689
+431,627
| +13% | +$10.6M | 0.01% | 1175 |
|
|
2022
Q3 | $94.8M | Sell |
3,324,062
-565,187
| -15% | -$16.2M | 0.01% | 1135 |
|
|
2022
Q2 | $95.8M | Buy |
3,889,249
+2,293,359
| +144% | +$83.9M | 0.01% | 1181 |
|
|
2022
Q1 | $90.1M | Buy |
1,595,890
+276,779
| +21% | +$15.8M | ﹤0.01% | 1368 |
|
|
2021
Q4 | $81.8M | Sell |
1,319,111
-10,307
| -0.8% | -$682K | ﹤0.01% | 1453 |
|
|
2021
Q3 | $84.3M | Buy |
1,329,418
+247,497
| +23% | +$19.1M | ﹤0.01% | 1415 |
|
|
2021
Q2 | $89.2M | Buy |
1,081,921
+2,353
| +0.2% | +$179K | ﹤0.01% | 1388 |
|
|
2021
Q1 | $79.4M | Buy |
1,079,568
+1,616
| +0.1% | +$127K | ﹤0.01% | 1408 |
|
|
2020
Q4 | $78.2M | Buy |
1,077,952
+281,110
| +35% | +$18.1M | ﹤0.01% | 1343 |
|
|
2020
Q3 | $38M | Buy |
796,842
+421,306
| +112% | +$17.9M | ﹤0.01% | 1646 |
|
|
2020
Q2 | $15.8M | Buy |
375,536
+202,117
| +117% | +$7.19M | ﹤0.01% | 2158 |
|
|
2020
Q1 | $4.68M | Buy |
173,419
+28,166
| +19% | +$918K | ﹤0.01% | 2659 |
|
|
2019
Q4 | $5.59M | Buy |
+145,253
| New | +$3.4M | ﹤0.01% | 2798 |
|
Other funds holding SWTX
State Street's SWTX Position: Q3 2025 in Review
State Street sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 2,994,000 shares — an estimated $141M sold.
State Street first reported a position in SWTX in Q4 2019 and held it in 23 quarters. The position peaked at $146M in Q1 2024. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.
- State Street reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
- State Street sold 2,994,000 SpringWorks Therapeutics shares in Q3 2025, an estimated $141M.
- State Street first reported a position in SpringWorks Therapeutics in Q4 2019 and held it in 23 quarters.
- State Street's SpringWorks Therapeutics position peaked at $146M in Q1 2024.
- 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.
Based on State Street's 13F filing for Q3 2025, filed 14 Nov 2025.